Fig. 3From: Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy optionsConcordance of ARMS-PCR and CapSMART for detection of EGFR and ALK fusion mutationsBack to article page